Eight stories for National Gay Men’s HIV/AIDS Awareness Day
Click Here to Manage Email Alerts
Today is National Gay Men’s HIV/AIDS Awareness Day, a day to end the stigma and recognize the disproportionate and ongoing impact of HIV/AIDS on gay, bisexual and other men who have sex with men.
The initiative was launched by the National Association of People with AIDS in 2008 and is observed every year on Sept. 27.
According to the CDC, of the 34,800 estimated new HIV infections reported in the U.S. in 2019, 24,500 (70%) were among gay and bisexual men. Despite accounting for this large proportion of new infections, the CDC reported that out of every 100 gay and bisexual men diagnosed with HIV in 2019, only 78 received some HIV care, 59 were retained in care and 68 were vitally suppressed.
In observance of National Gay Men’s HIV/AIDS Awareness Day, Healio has compiled a list of recent stories covering the latest HIV updates and the infection's impacts on the LGBTQ+ community.
Circumcision may reduce HIV risk among men who have sex with men
Voluntary medical male circumcision reduced the risk for HIV among men who have sex with men and could prove useful in countries where PrEP use is not widespread. Read more.
Sleep-disordered breathing more frequent in men with vs. without HIV
Researchers assessed and compared four different measures of sleep-disordered breathing between men with vs. without HIV and found that men with vs. men without HIV experienced more mild and moderate sleep-disordered breathing. Read more.
Decline in new HIV infections led by large decrease among young people, CDC data show
There were 12% fewer new HIV infections in the U.S. in 2021 compared with 2017, a reduction led by large decreases among young people, according to data shared by the CDC. Read more.
FDA loosens restrictions on blood donations for gay, bisexual men
The FDA finalized recommendations for blood donation, which will ultimately change time-based deferrals for men who have sex with men to individual risk-based questions to reduce the potential risk for HIV transmission. Read more.
HIV vaccine research ‘at a crossroads’ after recent failures
There are still no HIV vaccines currently available, and after the recent failures of three experimental vaccines in development, there are now zero candidates in late-stage trials. Read more.
USPSTF finalizes recommendation on HIV PrEP
The U.S. Preventive Services Task Force finalized its recommendation advocating for clinicians to prescribe PrEP to patients at increased risk for HIV. Read more.
Inclusive care is 'essential' for the LGBTQ+ community
Having access to an affirming provider is critical for reducing health disparities in the LGBTQ+ population, researchers determined using survey data from the Vanderbilt University Social Networks, Aging and Policy Study. Read more.
PrEP at 10: Medication ‘added a lot of energy to HIV prevention’
In 2012, more than 30 years into the fight against HIV, the FDA approved HIV PrEP, which became a “game-changer” in the decades-long fight to end the pandemic because it created confidence in HIV prevention without requiring major behavioral changes. Read more.